variant,gene_symbol,summary,clinical_importance,evidence,impact,frequency,category,inheritance,zygosity,PMIDs,dbSNP_ID,penetrance_score,build_37_chromosome,build_37_position,build_37_variant_allele,getev_report_url
ABCA4-G863A,ABCA4,"Various publications report this variant causes Stargardt Disease in a recessive manner, when combined with another more severe variant. Stargardt disease causes progressive vision loss and blindness.",High,Well-established,Pathogenic,0.0049,Hearing and vision,Recessive,Heterozygous,9054934;10090887;11919200;11973624;18285826,rs76157638,5,chr1,94517254,G,http://evidence.personalgenomes.org/genomes?display_genome_id=e23a21135f974aea45d6df3bd804212e7963e407&access_token=4fb91b5252e22efd30e48def9dd520d5
COL4A1-Q1334H,COL4A1,"This common variant has been associated with arterial stiffness and, in Japanese, a small increased risk of myocardial infarction (MI, a.k.a. heart attack). This last observation supported a dominant effect for this variant and, assuming a lifetime risk of 15% for MI, we estimate carriers have an additional risk of 0.5-3%.",Low,Likely,Pathogenic,0.32,Heart and circulatory,Dominant,Heterozygous,10334796;18077766;20031579,rs3742207,2,chr13,110818598,G,http://evidence.personalgenomes.org/genomes?display_genome_id=e23a21135f974aea45d6df3bd804212e7963e407&access_token=4fb91b5252e22efd30e48def9dd520d5
MTRR-I49M,MTRR,"This common variant (HapMap allele frequency of 31.3%) in a protein involved in folate (B9) and cobalamin (B12) metabolism and is often reported as ""MTRR I22M"" (an alternative transcript position). Mothers homozygous for this variant are associated with having around a increased chance of a child with Down syndrome (risk of 0.4%, average risk in population is 0.25%). Notably, age plays a far larger role in the rate of Down syndrome (risk is 4.5% for a mother 45-years-of-age), and it is unknown how this variant may combine with the effect of age. There are conflicting reports associating this variant with incidence of neural tube defects, possibly when combined with MTHFR A222V.",Low,Likely,Pathogenic,0.45,Anatomical and congenital;Metabolism;Nervous system,Recessive,Homozygous,10444342;10930360;11807890;12375236;15060097;15979034;17024475,rs1801394,1,chr5,7870973,G,http://evidence.personalgenomes.org/genomes?display_genome_id=e23a21135f974aea45d6df3bd804212e7963e407&access_token=4fb91b5252e22efd30e48def9dd520d5
RPGRIP1L-A229T,RPGRIP1L,"This variant is generally not considered pathogenic, but when combined with other severe variants it is associated with rare genetic diseases which involve retinal degeneration. Carrying this variant increases the risk of these diseases, but the overall increased risk is very small because the diseases are very rare.",Low,Likely,Pathogenic,0.056,Hearing and vision,Unknown,Heterozygous,19430481,rs61747071,0,chr16,53720436,T,http://evidence.personalgenomes.org/genomes?display_genome_id=e23a21135f974aea45d6df3bd804212e7963e407&access_token=4fb91b5252e22efd30e48def9dd520d5
rs5186,,"This common noncoding genetic variant has an allele frequency of ~30% and is associated with an increased risk of hypertension. If ~25% of non-carriers have hypertension, Bonnardeaux et al's data predict ~4% increased risk of hypertension per copy of this variant. This SNP is in the 3' noncoding region of the AGTR1 transcript (angiotensin II type 1 receptor), also known as AT2R1 or AT1R, which is a target of hypertension drugs.",Low,Likely,Pathogenic,0.21,Drug response;Heart and circulatory,Unknown,Heterozygous,"8021009;
11250978;11593098;16046653;16675453;17668390",rs5186,2,chr3,148459988,C,http://evidence.personalgenomes.org/genomes?display_genome_id=e23a21135f974aea45d6df3bd804212e7963e407&access_token=4fb91b5252e22efd30e48def9dd520d5
BRCA2-N372H,BRCA2,"This is a common variant of BRCA2 (HapMap allele frequency of 23%). The variant is weakly associated with an increased chance of breast cancer, and zygosity of the variant is associated with sex of children: male children are more likely to be homozygous for this variant, female children are more likely to be heterozygous.",Low,Uncertain,Pathogenic,0.24,Cancer,Recessive,Homozygous,11062481;15235023,rs144848,2,chr13,32906729,C,http://evidence.personalgenomes.org/genomes?display_genome_id=e23a21135f974aea45d6df3bd804212e7963e407&access_token=4fb91b5252e22efd30e48def9dd520d5
TGIF1-P83Shift,TGIF1,"Severe variants in this gene are associated with holoprosencephaly disorders when combined with loss-of-function variants in SHH. Haploinsufficiency was identified in some families with this condition. It is unclear how likely this variant is to occur in combination with an SHH variant, or what phenotypic effect the variant would have on its own.",Low,Uncertain,Pathogenic,0.14,Nervous system,Complex/Other,Heterozygous,10556296,rs11571510,1,,,,http://evidence.personalgenomes.org/genomes?display_genome_id=e23a21135f974aea45d6df3bd804212e7963e407&access_token=4fb91b5252e22efd30e48def9dd520d5
ELAC2-S217L,ELAC2,"Reported to be associated with increased susceptibility to prostate cancer, but later studies weaken the hypothesis. Xu et al.'s meta-analysis concludes that there is a small but significant increased risk (OR = 1.13). Assuming a lifetime risk of 16% for prostate cancer we calculate this leads to an increased risk of ~1.5% (17.5% total).",Low,Uncertain,Pathogenic,0.27,Cancer;Genital and urinary,Complex/Other,Heterozygous,12384782;15368467;18767027;20231859,rs4792311,2,chr17,12915009,A,http://evidence.personalgenomes.org/genomes?display_genome_id=e23a21135f974aea45d6df3bd804212e7963e407&access_token=4fb91b5252e22efd30e48def9dd520d5
H6PD-R453Q,H6PD,"This common variant may have a small pathogenic effect by contributing to cortisone reductase deficiency (a rare abnormality) when homozygous and combined with a serious pathogenic variant. The same authors have tested and ruled out a contribution to polycystic ovary syndrome (similar phenotype, more common disease).",Low,Uncertain,Pathogenic,0.31,Genital and urinary;Metabolism,Recessive,Heterozygous,12858176;15827106;16817821,rs6688832,1,chr1,9323910,A,http://evidence.personalgenomes.org/genomes?display_genome_id=e23a21135f974aea45d6df3bd804212e7963e407&access_token=4fb91b5252e22efd30e48def9dd520d5
RET-Y791F,RET,"Several publications asserted this variant caused familial medullary thyroid cancer in a dominant manner. However, a 2010 publication by Erlic et al. examined a larger set of controls, finding the variant no more common in cases than it was in controls. These authors conclude that the variant is not a serious cause of the disease, although they could not rule out a small effect on risk.",Low,Uncertain,Pathogenic,0.0013,Cancer,Unknown,Heterozygous,9506724;12000816;12409662;15531714;15870131;16118333;16705552;19826964;19906784,,0,chr10,43613908,T,http://evidence.personalgenomes.org/genomes?display_genome_id=e23a21135f974aea45d6df3bd804212e7963e407&access_token=4fb91b5252e22efd30e48def9dd520d5
SP110-L425S,SP110,"This variant is associated with a slightly increased risk of tuberculosis. It is unclear whether it is itself causal, or in linkage disequilibrium with some other causal variant that has a stronger effect.",Low,Uncertain,Pathogenic,0.86,Immune system,Unknown,Homozygous,16803959,rs3948464,1,chr2,231050715,G,http://evidence.personalgenomes.org/genomes?display_genome_id=e23a21135f974aea45d6df3bd804212e7963e407&access_token=4fb91b5252e22efd30e48def9dd520d5
WFS1-R611H,WFS1,"This nonsynonymous SNP is associated with Wolfram Syndrome (known as DIDMOAD), which is characterized by early-onset non-autoimmune diabetes mellitus, diabetes insipidus, optic atrophy, and deafness) and to adult Type Two Diabetes Mellitus.  The WFS1 gene maps to chromosome 4p16.3.  The variant has been shown to be statistically associated with type II diabetes in six UK studies and one study of Ashkenazi Jews (Sandhu, M., et al., Minton et al.).",Low,Uncertain,Not Reviewed,0.4,Hearing and vision;Immune system;Metabolism,Recessive,Heterozygous,17603484;17719176;23257691,rs734312,1,chr4,6303354,A,http://evidence.personalgenomes.org/genomes?display_genome_id=e23a21135f974aea45d6df3bd804212e7963e407&access_token=4fb91b5252e22efd30e48def9dd520d5
ERCC6-R1213G,ERCC6,"When homozygous, this variant may cause Cockayne Syndrome, which is a severe autosomal-recessive disorder characterized by abnormal early growth and development, abnormal sensitivity to sunlight, and premature aging. Cockayne Syndrome Type I and Type II lead to death in early childhood. Several other variants in the ERCC6 gene are linked to Cockayne Syndrome. This variant may also be linked to age-related macular degeneration like other ERCC6 variants, and has been linked to colorectal cancer in one study. ",Low,Uncertain,Pathogenic,0.2,Anatomical and congenital;Cancer;Hearing and vision,Recessive,Heterozygous,,rs2228527,0,chr10,50678369,C,http://evidence.personalgenomes.org/genomes?display_genome_id=e23a21135f974aea45d6df3bd804212e7963e407&access_token=4fb91b5252e22efd30e48def9dd520d5
DPYD-M166V,DPYD,Associated with DPYD deficiency and poor prognosis for chemotherapy w/ 5-flurorouracil. ,High,Likely,Pharmacogenetic,0.078,Other,Unknown,Heterozygous,11895907;14635116;19104657,rs2297595,5,chr1,98165091,C,http://evidence.personalgenomes.org/genomes?display_genome_id=e23a21135f974aea45d6df3bd804212e7963e407&access_token=4fb91b5252e22efd30e48def9dd520d5
CYP2C9-R144C,CYP2C9,"This variant, also called CYP2C9*2, is a pharmacogenetic variant that modulates sensitivity for Warfarin (due to reduced metabolism). This variant is associated with Caucasians. The FDA has approved reduced recommended Warfarin dosage based on the presence of this variant.",Moderate,Well-established,Pharmacogenetic,0.097,Drug response;Metabolism,Unknown,Heterozygous,8004131;15947090;17161452;17686967;19228618;19794411;19794412,rs1799853,3,chr10,96702047,T,http://evidence.personalgenomes.org/genomes?display_genome_id=e23a21135f974aea45d6df3bd804212e7963e407&access_token=4fb91b5252e22efd30e48def9dd520d5
TPMT-Y240C,TPMT,"Alone, this variant is known as TPMT*3C -- but often, especially in Caucasians, it is found together with another nonsynonymous variant (A154T) to produce the TPMT*3A variant. Both variants are associated with loss of thiopurine methyltransferase (TPMT) activity, although *3C is milder than *3A. Inability to metabolize thiopurine drugs can lead to severe adverse reactions. Heterozygotes may be advised to take a reduced dosage due to reduced metabolism of the drug.",Low,Well-established,Pharmacogenetic,0.046,Drug response;Metabolism,Complex/Other,Heterozygous,15228163;15298741;20154640;20354201,rs1142345,2,chr6,18130918,C,http://evidence.personalgenomes.org/genomes?display_genome_id=e23a21135f974aea45d6df3bd804212e7963e407&access_token=4fb91b5252e22efd30e48def9dd520d5
TPMT-A154T,TPMT,"Usually this variant is found in combination Y240C, forming the TPMT*3A variant. When alone, this variant produces the *3B variant. Both variants are associated with loss of thiopurine methyltransferase (TPMT) activity. Inability to metabolize thiopurine drugs can lead to severe adverse reactions. Heterozygotes may be advised to take a reduced dosage due to reduced metabolism of the drug.",Low,Likely,Pharmacogenetic,0.028,Drug response;Metabolism,Recessive,Heterozygous,15228163;15298741;20154640;20354201,rs1800460,2,chr6,18139228,T,http://evidence.personalgenomes.org/genomes?display_genome_id=e23a21135f974aea45d6df3bd804212e7963e407&access_token=4fb91b5252e22efd30e48def9dd520d5
rs1544410,,"rs1544410 is a Vitamin D Receptor (VDR) single nucleotide polymorphism. It is unlikely that it has functional significance because it is located in an intron (Liu et. al.), but it is in strong linkage disequilibrium with rs731236 (Dvornyk et al), which is located in an exon. ",Low,Uncertain,Pharmacogenetic,0.35,Other,Unknown,Heterozygous,,rs1544410,0,,,,http://evidence.personalgenomes.org/genomes?display_genome_id=e23a21135f974aea45d6df3bd804212e7963e407&access_token=4fb91b5252e22efd30e48def9dd520d5
ABCC6-R1268Q,ABCC6,This common polymorphism appears to not have a significant phenotypic impact. A few studies report weak but significant associations with plasma lipids (in Inuits) and thalidomide toxicity.,Low,Uncertain,Pharmacogenetic,0.22,Metabolism,Unknown,Heterozygous,10811882;10913334;11776382;20038957,rs2238472,1,chr16,16251599,T,http://evidence.personalgenomes.org/genomes?display_genome_id=e23a21135f974aea45d6df3bd804212e7963e407&access_token=4fb91b5252e22efd30e48def9dd520d5
FUT2-W154X,FUT2,"This recessive protective variant confers resistance to norovirus (which causes stomach flu). 20% of Caucasians and Africans are homozygous for this variant and are ""non-secretors"": they do not express ABO blood type antigens in their saliva or mucosal surfaces. Most strains of norovirus bind to these antigens in the gut, and so this non-secretor status confers almost total resistantance to most types of norovirus. There are notable exceptions, some strains of norovirus bind a different target and are equally infectious for secretors and non-secretors.",Moderate,Well-established,Protective,0.49,Blood;Immune system,Recessive,Heterozygous,7876235;12692541;19625485;20031047;22025362,rs601338,5,chr19,49206674,A,http://evidence.personalgenomes.org/genomes?display_genome_id=e23a21135f974aea45d6df3bd804212e7963e407&access_token=4fb91b5252e22efd30e48def9dd520d5
PRNP-M129V,PRNP,"This variant is associated with some protective effects for prion disease -- individuals homozygous for this variant are less susceptible to Creutzfeldt-Jakob, and Papua New Guinea individuals heterozygotes at this site are less susceptible to kuru.

",Low,Well-established,Protective,0.34,Other,Complex/Other,Heterozygous,18236005;19081515,rs1799990,0,chr20,4680251,G,http://evidence.personalgenomes.org/genomes?display_genome_id=e23a21135f974aea45d6df3bd804212e7963e407&access_token=4fb91b5252e22efd30e48def9dd520d5
CASP10-V410I,CASP10,"Reported to have a protective effect on breast cancer. If the lifetime risk of breast cancer is 12%, women with this variant may have a lower risk of 8-9% (30% less than average).",Low,Likely,Protective,0.047,Cancer,Dominant,Heterozygous,10412980;16251207,rs13010627,2,chr2,202074098,A,http://evidence.personalgenomes.org/genomes?display_genome_id=e23a21135f974aea45d6df3bd804212e7963e407&access_token=4fb91b5252e22efd30e48def9dd520d5
KCNJ11-K23E,KCNJ11,"This variant is associated with decreased risk of type 2 diabetes. It is unclear whether this variant has additive effects, or acts in a dominant or recessive manner. Assuming diabetes has a lifetime risk of 36%, we estimate a decreased risk of around 1-2% per copy of this variant.",Low,Likely,Protective,0.74,Metabolism,Unknown,Heterozygous,17463246;17463248;20054294,rs5219,2,chr11,17409572,C,http://evidence.personalgenomes.org/genomes?display_genome_id=e23a21135f974aea45d6df3bd804212e7963e407&access_token=4fb91b5252e22efd30e48def9dd520d5
MLH1-I219V,MLH1,"Computational evidence, functional assays, and case/control studies suggest this variant is probably benign.",Low,Uncertain,Benign,0.24,Other,Dominant,Heterozygous,11781295;12810663;17074586;17510385;17870204;19863800;20301390;22631669,rs1799977,0,chr3,37053568,G,http://evidence.personalgenomes.org/genomes?display_genome_id=e23a21135f974aea45d6df3bd804212e7963e407&access_token=4fb91b5252e22efd30e48def9dd520d5
LOXL1-R141L,LOXL1,"Associated with exfoliative glaucoma & syndrome (XFG & XFS) in various populations, but with contradicting results (protective in Caucasians, pathogenic in Japanese). Based on this it seems the variation itself -- although it affects protein structure -- is not itself causing disease. Instead it is likely associated with other nearby causal variants. As such, it is evaluated as benign by GET-Evidence (which focuses on reporting causal variants). See detailed variant report for disease risk associations.",Low,Uncertain,Benign,0.26,Hearing and vision,Complex/Other,Heterozygous,17690259;18450598;20142848,rs1048661,,chr15,74219546,T,http://evidence.personalgenomes.org/genomes?display_genome_id=e23a21135f974aea45d6df3bd804212e7963e407&access_token=4fb91b5252e22efd30e48def9dd520d5
TYR-S192Y,TYR,This variant is reported to affect skin pigmentation. It is associated with lighter skin in South Asians (OR 4-5) and with a lack of freckles in Europeans (OR 1.3).,Low,Uncertain,Benign,0.27,Skin,Unknown,Heterozygous,17952075;17999355,rs1042602,,chr11,88911696,A,http://evidence.personalgenomes.org/genomes?display_genome_id=e23a21135f974aea45d6df3bd804212e7963e407&access_token=4fb91b5252e22efd30e48def9dd520d5
PCSK9-G670E,PCSK9,This variant is likely benign. ,Low,Uncertain,Benign,0.89,Other,Unknown,Homozygous,19351729,rs505151,,chr1,55529187,A,http://evidence.personalgenomes.org/genomes?display_genome_id=e23a21135f974aea45d6df3bd804212e7963e407&access_token=4fb91b5252e22efd30e48def9dd520d5
PALB2-E672Q,PALB2,Probably benign.,Low,Uncertain,Benign,0.024,Other,Unknown,Heterozygous,17200668,rs45532440,,chr16,23641461,G,http://evidence.personalgenomes.org/genomes?display_genome_id=e23a21135f974aea45d6df3bd804212e7963e407&access_token=4fb91b5252e22efd30e48def9dd520d5
ABCA4-R943Q,ABCA4,"This is a polymorphism in a gene associated with Stargardt disease. Although it has a slight detectable effect in functional study, it is common in control groups and is not believed to have any significant pathogenic effect.",Low,Uncertain,Benign,0.032,Hearing and vision,Unknown,Heterozygous,9295268;11919200,rs1801581,,chr1,94512565,T,http://evidence.personalgenomes.org/genomes?display_genome_id=e23a21135f974aea45d6df3bd804212e7963e407&access_token=4fb91b5252e22efd30e48def9dd520d5
FMO3-V257M,FMO3,"This common variant (HapMap allele frequency of 9.2%) appears to have no functional effect. OMIM has recorded it as having been seen homozygously in an individual with Trimethylaminuria, but Treacy et al. 1998 conclude it is a polymorphism.",Low,Uncertain,Benign,0.057,Metabolism,Unknown,Heterozygous,9536088,rs1736557,,chr1,171080080,A,http://evidence.personalgenomes.org/genomes?display_genome_id=e23a21135f974aea45d6df3bd804212e7963e407&access_token=4fb91b5252e22efd30e48def9dd520d5
APOB-Y1422C,APOB,This position is almost certainly an error in the HG18 reference sequence. ,Low,Uncertain,Benign,1.0,Other,Unknown,Homozygous,,rs568413,,chr2,21235475,C,http://evidence.personalgenomes.org/genomes?display_genome_id=e23a21135f974aea45d6df3bd804212e7963e407&access_token=4fb91b5252e22efd30e48def9dd520d5
RP1-N985Y,RP1,"Probably benign. One report linked this variant to high triglycerides, but a later paper found a nearby SNP with similar association and suggests that both findings are caused by linkage to an undiscovered causal variant.",Low,Uncertain,Benign,0.35,Metabolism,Unknown,Heterozygous,12764676;19364639,rs2293869,,chr8,55539395,T,http://evidence.personalgenomes.org/genomes?display_genome_id=e23a21135f974aea45d6df3bd804212e7963e407&access_token=4fb91b5252e22efd30e48def9dd520d5
TAS2R38-A49P,TAS2R38,"This variant is strongly associated with causing the ""taster"" phenotype of phenylthiocarbamine (PTC) in a dominant manner.",Low,Uncertain,Benign,0.43,Other,Unknown,Heterozygous,12595690;15883422;20675712,rs713598,,chr7,141673345,G,http://evidence.personalgenomes.org/genomes?display_genome_id=e23a21135f974aea45d6df3bd804212e7963e407&access_token=4fb91b5252e22efd30e48def9dd520d5
TAS2R38-I296V,TAS2R38,"This variant is associated with ""taster"" status of PTC, along with 49P and 262A. Due to linkage disequilibrium, the independent effects of positions 296 and 262 is unclear. The presence of 49P confers taster status in a dominant fashion, but in the absence of 49P, the presence of 262A/296V is still positively associated with tasting PTC.",Low,Uncertain,Benign,0.46,Other,Unknown,Heterozygous,12595690;20675712,rs10246939,,chr7,141672604,C,http://evidence.personalgenomes.org/genomes?display_genome_id=e23a21135f974aea45d6df3bd804212e7963e407&access_token=4fb91b5252e22efd30e48def9dd520d5
SLC45A2-L374F,SLC45A2,"Pigmentation allele for non-black hair, and consequently, possible increased susceptibility to malignant melanoma.",Low,Uncertain,Benign,0.69,Cancer,Unknown,Homozygous,15714523;17044855;18563784;18806926,rs16891982,,chr5,33951693,G,http://evidence.personalgenomes.org/genomes?display_genome_id=e23a21135f974aea45d6df3bd804212e7963e407&access_token=4fb91b5252e22efd30e48def9dd520d5
TPCN2-G734E,TPCN2,Pigmentation allele.,Low,Uncertain,Benign,0.29,Other,Unknown,Homozygous,18488028,rs3829241,,chr11,68855363,A,http://evidence.personalgenomes.org/genomes?display_genome_id=e23a21135f974aea45d6df3bd804212e7963e407&access_token=4fb91b5252e22efd30e48def9dd520d5
